Yaron Sfadyah
Chief Executive Officer Coltac Therapeutics
Seminars
Tuesday 27th October 2026
From Microbes to Degradation: Developing a b-catenin Degrader – From Bacteria to in-vivo
2:00 pm
- Sharing Coltac’s pre-clinical data, degrading b-catenin for CRC
- Leveraging bacteria for the discovery of MG
- What’s next in MG discovery and development
